Investor
Teikoku Ventures
Independent VC Domestic (Japan)
2026 activity
- 1 tracked 2026 equity round(s)
- Participated in rounds totalling ¥400M of equity. This is the sum of whole rounds' equity, including other investors' money; it is not this investor's own investment. Debt is not included.
Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 5 Oct 2026 | CTCelaid Therapeutics | Series B 2nd Close | ¥400M | Shionogi & Co.Teikoku Ventures | BiotechDeep tech |